US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 46.390
- -1.610-3.35%
Close Nov 27 16:00 ET
- 44.080
- -2.310-4.98%
Post 20:01 ET
2.43BMarket Cap-39649P/E (TTM)
49.690High46.300Low650.13KVolume48.100Open48.000Pre Close30.53MTurnover1.71%Turnover RatioLossP/E (Static)52.48MShares65.60052wk High3.71P/B1.76BFloat Cap7.79052wk Low--Dividend TTM38.01MShs Float65.600Historical High--Div YieldTTM7.06%Amplitude5.650Historical Low46.963Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Janux Therapeutics Stock Forum
lets go …. 79 solid pt and opportunities for profits off the current value (46.00)
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...
A quick recap for the month ending April 30, 2024.
No comment yet